A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of E

A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants with Primary Biliary Cholangitis (PBC)

Abierta

Código protocolo: CLIN-60190-454
Código EudraCT: No aplica
Grupo de investigación: Enfermedades Hepáticas
Servicio: Hepatología
Investigador/a principal: Villagrasa Vilella, Ares Aurora
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III